NCT02429505View on ClinicalTrials.gov

Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Leishmaniasis
Interventions
DRUG

Miltefosine

miltefosine: target 2.5 mg/kg/day for 28 days

Trial Locations (1)

20837

Fast-Track Drugs and Biologics, LLC, Poolesville

Sponsors
All Listed Sponsors
lead

Knight Therapeutics (USA) Inc

INDUSTRY